Amber Donnelly, PhD, MPH, SCT(ASCP), director of the Cytotechnology program, has recently been elected to serve a 4-year term on the Executive Board of the American Society of Cytopathology (ASC). This is the highest position a cytotechnologist member can hold in the national organization.
The society is comprised of both Pathologist and Cytotechnologist members. The ASC’s diverse membership also includes representatives from other countries who share a vision of education, research, and continuous improvement in the standards and quality of patient care. The ASC is a unique society that provides a forum where physicians and cytotechnologists can interact and network with each other.
Congratulations, Dr. Donnelly!